Abstract
Aromatase (CYP19) is the key enzyme in the biosynthesis of estrogens. In humans, it is expressed in a tissue- and promoter-specific manner. In hormone-dependent breast cancer, CYP19 is overexpressed through the activation of several additional promoters (PII, I.3 and I.7) that are normally inactive in the healthy mammary gland. In the normal mammary gland, low basal CYP19 expression is regulated by the I.4 promoter, which is also active in adipose tissue. Here, we highlight our recent study of the effects of neonicotinoid pesticides on the promoter-specific expression of CYP19 in various human in vitro models. We also discuss the implications of endocrine disruption by environmental chemicals for the development of hormone-dependent diseases, such as breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
